GE Healthcare buys nanofibre purification tech firm Puridify
GE says it will continue to invest in Puridify’s early-stage FibroSelect technology to bring it to full commercialisation.
Archives for November 28, 2017
Roller bottles to bioreactors: Microbix ups antigen capacity by 500%
Microbix says it has successfully converted its production process from roller bottles to bioreactors to cope with growing demand for its antigens.
Lucentis biosimilar: Formycon eyes 2020 for US launch
Formycon and its commercialisation partner bioeq have positioned themselves for the potential launch of a Lucentis (ranibizumab) biosimilar in 2020.